Clinical characteristics of polyglandular autoimmune syndromes in pediatric age: an observational study

Bruno Bouça1, Andreia Nogueira2, Joana Caetano3

  • 1Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal.

Insights

Polyglandular autoimmune syndromes (PAS) are often underestimated in children. This study found PAS type 3 most common in pediatric patients with autoimmune diseases like type 1 diabetes and thyroid disease.

Area of Science:

  • Endocrinology
  • Immunology
  • Pediatrics

Background:

  • Polyglandular autoimmune syndromes (PAS) involve multiple autoimmune diseases (AID).
  • While PAS type 1 is common in childhood, other PAS types are less studied in pediatric populations.
  • The prevalence of various PAS types in children may be underestimated.

Purpose of the Study:

  • To determine the prevalence of different PAS types in a pediatric cohort.
  • To describe and classify PAS manifestations in children with specific endocrine autoimmune diseases.
  • To compare the age of onset of autoimmune diseases in children with and without PAS.

Main Methods:

  • A 10-year retrospective study of 879 children diagnosed with Diabetes mellitus type 1 (DM1), autoimmune thyroid disease (AITD), or Addison's disease (AD).
  • Evaluation for the presence of multiple autoimmune diseases to diagnose and classify PAS types.
  • Statistical analysis to compare disease onset age between children with PAS and monoglandular conditions.

Main Results:

  • 35 children were diagnosed with PAS, with PAS type 3 being the most prevalent (65.7%).
  • Autoimmune thyroid disease (AITD) was the most frequently observed autoimmune disease (74.3%) among PAS patients.
  • PAS type 1 was not diagnosed in this cohort.
  • Children with PAS presented with DM1 and AITD at a significantly younger age compared to those with single autoimmune conditions.

Conclusions:

  • This study provides novel insights into the prevalence of diverse PAS types within a pediatric endocrine patient group.
  • Early detection of autoantibodies is crucial for timely PAS diagnosis, especially in individuals with Addison's disease.
  • Lifelong screening for PAS is recommended for pediatric patients diagnosed with Addison's disease.
Abstract

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
723
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
11
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
898
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
16
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
9
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.9K